2024 연구자 정보 (26 / 1073)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Lian, Jane B. (Lian, JB) |
Univ Vermont, Dept Biochem, Coll Med, Burlington, VT USA Univ Vermont, Ctr Canc, Coll Med, Burlington, VT USA |
|
|
[JCR상위 1.1%] Cbfβ prevents articular cartilage degeneration | SCIE | 1.1 |
ORTHOPEDICS RHEUMATOLOGY |
|||
|
Liang, X. (Liang, X) |
HuBei Canc Hosp, Dept Oncol, Wuhan, Peoples R China |
|
|
[JCR상위 1.1%] Real-world treatment (Tx) patterns in patients (pts) with HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (HER2+aGC/GEJC) in East Asia (HER2+GASTA) | SCIE | 1.1 | ONCOLOGY | |||
|
Luo, S. (Luo, S) |
Zhengzhou Univ, Dept Med Oncol, Affiliated Canc Hosp, Zhengzhou, Peoples R China Henan Canc Hosp, Zhengzhou, Peoples R China |
|
|
[JCR상위 1.1%] Real-world treatment (Tx) patterns in patients (pts) with HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (HER2+aGC/GEJC) in East Asia (HER2+GASTA) | SCIE | 1.1 | ONCOLOGY | |||
|
Madabhushi, A. (Madabhushi, A) |
Emory Univ, Biomed Engn, Atlanta, GA 30322 USA Picture Hlth, Cleveland, OH USA |
AAG-2908-2019 Madabhushi, Anant |
|
[JCR상위 1.1%] Tumor-immune spatial interactions on NSCLC H&E slide images predicts immunotherapy response: Preliminary external validation [JCR상위 2.3%] Semi-Automated NSCLC Segmentation and RECIST Measurement: Bridging the Gap Between Speed and Radiologist-Level Accuracy |
SCIE | 1.1 |
ONCOLOGY RESPIRATORY SYSTEM |
|||
|
Maghsoudi, O. Haji (Maghsoudi, OH) |
Picture Hlth, Cleveland, OH USA |
|
|
[JCR상위 1.1%] Tumor-immune spatial interactions on NSCLC H&E slide images predicts immunotherapy response: Preliminary external validation | SCIE | 1.1 | ONCOLOGY | |||
|
Meeks, J. J. (Meeks, JJ) |
Northwestern Univ, Feinberg Sch Med, Dept Urol Biochem & Mol Genet, Chicago, IL USA |
|
|
[JCR상위 1.1%] A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | SCIE | 1.1 | ONCOLOGY | |||
|
Modi, S. (Modi, S) |
Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY USA |
|
|
[JCR상위 1.1%] Exploratory biomarker analysis of trastuzumab deruxtecan versus treatment of physician's choice in HER2-low, hormone receptorepositive metastatic breast cancer in DESTINY-Breast04 | SCIE | 1.1 | ONCOLOGY | |||
|
Moon, Heewan (Moon, H) |
HifilM, 24 Deokseongsandan 2 Ro,Idong Eup, Yongin 17130, Gyeonggi Do, South Korea |
|
|
[JCR상위 1.1%] Membrane reciprocation and quorum quenching: An innovative combination for fouling control and energy saving in membrane bioreactors | SCIE | 1.1 |
ENVIRONMENTAL SCIENCES WATER RESOURCES ENGINEERING, ENVIRONMENTAL |
chookh@knu.ac.kr | ||
|
Moon, So Yeon (Moon, SY) |
Rural Dev Adm RDA, Natl Inst Crop Sci NICS, Div Crop Fdn, Wonju 55365, South Korea |
|
|
[JCR상위 1.1%] Wheat seedlings extract ameliorates sarcopenia in aged mice by regulating protein synthesis and degradation with anti-inflammatory and mitochondrial biogenesis effects | SCIE | 1.1 |
CHEMISTRY, MEDICINAL INTEGRATIVE & COMPLEMENTARY MEDICINE PHARMACOLOGY & PHARMACY PLANT SCIENCES |
eykwon@knu.ac.kr | ||
|
Na, Byoung-Kuk (Na, BK) |
교신저자 |
Gyeongsang Natl Univ, Coll Med, Dept Parasitol & Trop Med, Jinju 52727, South Korea Gyeongsang Natl Univ, Inst Hlth Sci, Coll Med, Jinju 52727, South Korea Gyeongsang Natl Univ, Dept Convergence Med Sci, Jinju 52727, South Korea Gyeongsang Natl Univ, Coll Med, Inst Med Sci, Jinju 52727, South Korea Gyeongsang Natl Univ, Coll Med, Dept Parasitol & Trop Med, Dept Convergence Med Sci, Jinju 52727, South Korea |
KPY-6354-2024 Na, b |
0000-0002-6734-1673 Na, Byoung-Kuk |
[JCR상위 1.1%] (-)-Epicatechin reveals amoebicidal activity against Acanthamoeba castellanii by activating the programmed cell death pathway [JCR상위 54.3%] Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in Gia Lai Province, Vietnam [JCR상위 77.7%] Population genetic analysis of Plasmodium vivax vir genes in Pakistan |
SCIE | 1.1 |
CHEMISTRY, MEDICINAL INTEGRATIVE & COMPLEMENTARY MEDICINE PHARMACOLOGY & PHARMACY PLANT SCIENCES PARASITOLOGY |
bkna@gnu.ac.kr jmkang@gnu.ac.kr kuku1819@knu.ac.kr huynhquangimpe@yahoo.com ykg.kuku1819@knu.ac.kr |
|
|
Niikura, N. (Niikura, N) |
Tokai Univ, Sch Med, Dept Breast Oncol, Hiratsuka, Kanagawa, Japan |
|
|
[JCR상위 1.1%] Exploratory biomarker analysis of trastuzumab deruxtecan versus treatment of physician's choice in HER2-low, hormone receptorepositive metastatic breast cancer in DESTINY-Breast04 | SCIE | 1.1 | ONCOLOGY | |||
|
Nishiyama, H. (Nishiyama, H) |
Univ Tsukuba, Dept Urol, Tsukuba, Ibaraki, Japan |
|
|
[JCR상위 1.1%] A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | SCIE | 1.1 | ONCOLOGY | |||
|
Oh, D-Y. (Oh, DY) |
제1저자 | Seoul Natl Univ Hosp, Internal Med Dept, Seoul, South Korea |
|
|
[JCR상위 1.1%] Real-world treatment (Tx) patterns in patients (pts) with HER2-positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (HER2+aGC/GEJC) in East Asia (HER2+GASTA) | SCIE | 1.1 | ONCOLOGY | ||
|
Oh, S. (Oh, S) |
Jeonju Presbyterian Med Ctr, Jeonju, South Korea Korea Inst Radiol & Med Sci KIRAMS, Seoul, South Korea |
|
|
[JCR상위 1.1%] Long-term clinical outcomes of acute myocardial infarction based on a center's experience with IVUS in the contemporary drug-eluting stent era [JCR상위 4.5%] In Vivo Behavior Study of Chemical in Household Products in Rats using Preclinical Techniques in Nuclear Medicine: [Cu⁻⁶⁴]Cu-DOTA-Branched polyethylenimine ([Cu⁻⁶⁴]Cu-DOTA-BPEI) |
SCIE | 1.1 |
CARDIAC & CARDIOVASCULAR SYSTEMS RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING |
aquinaskwon@gmail.com | ||
|
Ozguroglu, M. (Ozguroglu, M) |
Istanbul Univ Cerrahpasa, Cerrahpasa Med Sch, Dept Internal Med, Istanbul, Turkey |
|
|
[JCR상위 1.1%] A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | SCIE | 1.1 | ONCOLOGY |
페이지 이동: